. 2020 Mar 3;11(1):156–159. doi: 10.1055/s-0039-3402675
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
Fig. 1.
Boxplot showing malondialdehyde for stroke cases and controls.